» Articles » PMID: 26022185

Intracellular Calcium Attenuates Late Current Conducted by Mutant Human Cardiac Sodium Channels

Overview
Date 2015 May 30
PMID 26022185
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mutations of the cardiac voltage-gated sodium channel (SCN5A gene encoding voltage-gated sodium channel [NaV1.5]) cause congenital long-QT syndrome type 3 (LQT3). Most NaV1.5 mutations associated with LQT3 promote a mode of sodium channel gating in which some channels fail to inactivate, contributing to increased late sodium current (INaL), which is directly responsible for delayed repolarization and prolongation of the QT interval. LQT3 patients have highest risk of arrhythmia during sleep or during periods of slow heart rate. During exercise (high heart rate), there is elevated steady-state intracellular free calcium (Ca(2+)) concentration. We hypothesized that higher levels of intracellular Ca(2+) may lower arrhythmia risk in LQT3 subjects through effects on INaL.

Methods And Results: We tested this idea by examining the effects of varying intracellular Ca(2+) concentrations on the level of INaL in cells expressing a typical LQT3 mutation, delKPQ, and another SCN5A mutation, R225P. We found that elevated intracellular Ca(2+) concentration significantly reduced INaL conducted by mutant channels but not wild-type channels. This attenuation of INaL in delKPQ expressing cells by Ca(2+) was not affected by the CaM kinase II inhibitor KN-93 but was partially attenuated by truncating the C-terminus of the channel.

Conclusions: We conclude that intracellular Ca(2+) contributes to the regulation of INaL conducted by NaV1.5 mutants and propose that, during excitation-contraction coupling, elevated intracellular Ca(2+) suppresses mutant channel INaL and protects cells from delayed repolarization. These findings offer a plausible explanation for the lower arrhythmia risk in LQT3 subjects during fast heart rates.

Citing Articles

NaV1.6 dysregulation within myocardial T-tubules by D96V calmodulin enhances proarrhythmic sodium and calcium mishandling.

Tarasov M, Struckman H, Olgar Y, Miller A, Demirtas M, Bogdanov V J Clin Invest. 2023; 133(7).

PMID: 36821382 PMC: 10065082. DOI: 10.1172/JCI152071.


Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes.

Ko T, Jeong D, Yu B, Song J, Le Q, Woo S Pflugers Arch. 2022; 475(2):217-231.

PMID: 36274100 PMC: 9849166. DOI: 10.1007/s00424-022-02754-z.


: A novel class of potential antiarrhythmic compounds.

Abdelsayed M, Page D, Ruben P Front Pharmacol. 2022; 13:976903.

PMID: 36249789 PMC: 9554508. DOI: 10.3389/fphar.2022.976903.


Elementary mechanisms of calmodulin regulation of Na1.5 producing divergent arrhythmogenic phenotypes.

Kang P, Chakouri N, Diaz J, Tomaselli G, Yue D, Ben-Johny M Proc Natl Acad Sci U S A. 2021; 118(21).

PMID: 34021086 PMC: 8166197. DOI: 10.1073/pnas.2025085118.


Revisiting atrial pacing in the long QT genotype era.

Webster G J Cardiovasc Electrophysiol. 2021; 32(3):790-791.

PMID: 33527616 PMC: 7954960. DOI: 10.1111/jce.14921.


References
1.
Motoike H, Liu H, Glaaser I, Yang A, Tateyama M, Kass R . The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol. 2004; 123(2):155-65. PMC: 2217430. DOI: 10.1085/jgp.200308929. View

2.
Wingo T, Shah V, Anderson M, Lybrand T, Chazin W, Balser J . An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol. 2004; 11(3):219-25. DOI: 10.1038/nsmb737. View

3.
Kim J, Ghosh S, Liu H, Tateyama M, Kass R, Pitt G . Calmodulin mediates Ca2+ sensitivity of sodium channels. J Biol Chem. 2004; 279(43):45004-12. DOI: 10.1074/jbc.M407286200. View

4.
Stuhmer W, Conti F, Suzuki H, Wang X, Noda M, Yahagi N . Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989; 339(6226):597-603. DOI: 10.1038/339597a0. View

5.
Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T . The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun. 1991; 181(3):968-75. DOI: 10.1016/0006-291x(91)92031-e. View